Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 11;370(6522):1277-1279.
doi: 10.1126/science.abf5084. Epub 2020 Dec 3.

COVID-19 vaccine trial ethics once we have efficacious vaccines

David Wendler  1 , Jorge Ochoa  2 , Joseph Millum  2   3 , Christine Grady  2 , Holly A Taylor  2
Affiliations

COVID-19 vaccine trial ethics once we have efficacious vaccines

David Wendler et al. Science. .
No abstract available

PubMed Disclaimer

Figures

None
A volunteer receives an injection as part of a phase 3 trial of the vaccine candidate developed by Pfizer and BioNTech.
See this image and copyright information in PMC

References

    1. Bioworld, Biopharma products in development for COVID-19 (2020); www.bioworld.com/COVID19products.
    1. Corum J, Wee SL, Zimmer C, Coronavirus vaccine tracker (2020); www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html.
    1. FDA, “Development and licensure of vaccines to prevent COVID-19: Guidance for industry” (FDA-2020-D-1137, FDA, 2020); www.fda.gov/media/139638/download.
    1. Pfizer, “Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study,” 9 November 2020; www.pfizer.com/news/press-release/press-release-detail/pfizer-and-bionte....
    1. Moderna, “Moderna’s COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the phase 3 COVE study,” 16 November 2020; https://investors.modernatx.com/news-releases/news-release-details/moder....

Publication types